Narcolepsy drug moves to Phase III trial for post-stroke fatigue

Australian researchers are hoping to build on promising results for modafinil in debilitating fatigue after stroke with a larger phase III trial. The MIDAS trial, published last year in Stroke, found that modafinil effectively alleviated fatigue and improve quality of life in patients who had experienced a stroke. And according to study author Dr Tom Lillicrap ...

Already a member?

Login to keep reading.

© 2022 the limbic